A new national service which will provide comprehensive care and support for challenging mental health patients in their own homes following discharge from hospital is being welcomed by lead clinicians and patient advocates. Vicky Wadsworth, head of the mental health department at Roebucks solicitors in Blackburn, which acts on behalf of hundreds of patients, said: "There is a huge gap in care provision that this service can help fill. Health service outreach teams are desperately overstretched and cannot provide the sustained intensive treatment and rehabilitation support that many patients require. In some cases, this means that patients can't be moved on into the community and so remain confined in secure facilities unnecessarily.
When people lose their ability to memorize data they have amnesia. Amnesia also refers to an inability to recall information that is stored in memory. In simple terms, amnesia is the loss of memory. The causes of amnesia may be organic or functional. Organic causes may include brain damage through injury, or the use of specific drugs - usually sedative drugs. Amnesia may be one of the symptoms of some degenerative brain diseases, such as Alzheimer's disease. Functional causes are psychological factors, such as defense mechanisms. People with amnesia also find it hard to imagine the future, because our constructions of future scenarios are closely linked to our recollections of past experiences.
The number of suicides in England are at an all-time low, Care Services Minister Phil Hope announced as he published the latest annual report on suicide prevention. The new figures out today show: - The suicide rate for 2007, the most recent available, was the lowest recorded at 7.5 deaths per 100, 000 population. - There continues to be a sustained fall in the rate of suicide among young men under the age of 35. - There has also been a further reduction in suicides amongst mental health in-patients, from 216 in 1997 to 136 in 2006 (latest data). - There has been a fall in suicides in prisons, from 65 in 1997 to 60 in 2008. The 2008 figure is down from 88 in 2007, although trend has fluctuated.
Selected highlights from a new study on immigration, health and gender roles: Mexican wives who stay home when their husbands immigrate to the United States for work have poorer mental health than a comparison group. Shifting gender roles seem to be equally as stressful as the husbands' absence. "Popular American psychology would suggest that their newfound independence might ease the stress of single-handedly managing the household. Being apart from their husbands, who go to the United States to work, does nothing beneficial for their mental health." - Jared Wilkerson, lead study author The study of 47 "sending" and 47 "non-sending" Mexican wives will be published in the July issue of the journal Health Care for Women International.
Promoting new discoveries in brain research and mental disorders Mental disorders are a global problem and represent one of the biggest challenges for health care systems. In the world, there are some 500 million people suffering from mental disorders, and in the European Union, mental disorders range as one of the leading causes of disease burden. What makes the situation worse is that the prevalence of mental and neurological disorders is expected to grow for a variety of reasons: an ageing population will lead to an increased risk for age-related mental illness and neurological disorders, especially dementia and Parkinson¬ s disease. By 2040, Alzheimer¬ s disease will double in Western and triple in Eastern Europe (Jan√ -Llopis & Gabilondo, 2008).
22nd Congress of the European College of Neuropsychopharmacology (ECNP), 12 - 16 September 2009, Istanbul, Turkey Professor William T. Carpenter from the Maryland Psychiatric Research Center, University of Maryland School of Medicine, USA, will present the major directions of current scientific activities and point to the clinical implications of this paradigm shift, which is influencing virtually all aspects of schizophrenia research. He will explain that impaired cognition and negative symptoms represent attractive indications for drug development, raising the possibility of very early intervention and secondary prevention. Schizophrenia is a major public health problem: Affecting almost 1% of the world's population, it takes an enormous economic and social toll in addition to the distress, dysfunction, disability and mortality for those afflicted with this disease.